Found 22 matching trials
P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome PHASE2 The primary purpose of the study is to investigate the effects of high-dose...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber PHASE2 The purpose of this study is to determine whether long-acting octreotide is...
Show More Learn More & Join Trial
Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) N/A An observational time and motion study in a clinical oncology setting is ut...
Show More Location
The University of Arizona Cancer Center
Learn More & Join Trial
Safety and Efficacy of Octreotide Long Acting Release (LAR) in Treatment Naïve Acromegalic Patients PHASE3 Currently, the first line treatment for acromegaly is surgery, in order to ...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly PHASE3 This study will evaluate the efficacy and safety of pasireotide LAR 40 and ...
Show More Location
University of Michigan
Learn More & Join Trial
Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients PHASE4 The SAUNA trial is a multi-national, multi-centre, open-label, randomised, ...
Show More Learn More & Join Trial
A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide PHASE4 This study is being done to evaluate differences in patient experience duri...
Show More Location
Memorial Sloan Kettering Basking Ridge
Learn More & Join Trial
5FU and Octreotide Long-acting Release (LAR) for Neuroendocrine Tumors PHASE2 Well differentiated neuroendocrine carcinomas have low proliferative activi...
Show More Location
Federico Castiglione
Learn More & Join Trial
Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis PHASE2 To evaluate in combination with corticosteroid and local standard medical c...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Octreotide LAR in the Induction of Immunologic Response in NENs Patients PHASE2 Evaluating the impact of OCTREOTIDE LAR on the immune response by studying ...
Show More Location
Istitute Nazionale Tumori - Fondazione G. Pascale
Learn More & Join Trial